GRAIL, Inc. Appoints New CMO, Director

TL;DR

GRAIL appoints new CMO and adds a director to the board.

AI Summary

GRAIL, Inc. announced on October 21, 2024, the appointment of Dr. Tracey Gronemus as Chief Medical Officer and the election of Ms. Jennifer D. Johnson to its Board of Directors. The company also disclosed compensatory arrangements for certain officers, though specific details and dollar amounts were not provided in this filing.

Why It Matters

Changes in key leadership roles like Chief Medical Officer and Board of Directors can signal strategic shifts or new directions for a company's medical and governance strategies.

Risk Assessment

Risk Level: low — This filing primarily concerns routine executive appointments and board changes, with no immediate financial or operational risks indicated.

Key Players & Entities

• GRAIL, Inc. (company) — Registrant
• Dr. Tracey Gronemus (person) — Appointed Chief Medical Officer
• Ms. Jennifer D. Johnson (person) — Elected to Board of Directors
• October 21, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share GRAL The Nasdaq Global Select
• $50,000 — g receipt of an annual cash retainer of $50,000 for service on the Board, an additional
• $10,000 — , an additional annual cash retainer of $10,000 for service on the Audit Committee, an
• $7,500 — , an additional annual cash retainer of $7,500 for service on the Compensation Committ
• $5,000 — d an additional annual cash retainer of $5,000 for service on the Nominating and Corpo
• $250,000 — nits having a grant date value equal to $250,000, which will vest in full on the earlier
• $1.6 million — equal to an aggregate of approximately $1.6 million to Sutter Institute for Medical Researc

Filing Documents

• gral-20241021.htm (8-K) — 31KB
• ex991_pressreleaseoctober2.htm (EX-99.1) — 11KB
• image_0a.jpg (GRAPHIC) — 31KB
• 0001628280-24-043305.txt ( ) — 214KB
• gral-20241021.xsd (EX-101.SCH) — 2KB
• gral-20241021_lab.xml (EX-101.LAB) — 22KB
• gral-20241021_pre.xml (EX-101.PRE) — 13KB
• gral-20241021_htm.xml (XML) — 3KB

02

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Election of Directors On October 21, 2024, the Board of Directors (the "Board") of GRAIL, Inc. (the "Company") appointed Sarah Krevans to the Board, effective immediately. Ms. Krevans will serve as a Class II director, for a term expiring at the annual meeting of stockholders to be held in 2026 or until her earlier death, resignation or removal. Ms. Krevans was also appointed to serve as an additional member of the Board's Audit Committee, Compensation Committee and Nominating and Governance Committee. Ms. Krevans is eligible to participate in the Company's Non-Employee Director Compensation Program, including receipt of an annual cash retainer of $50,000 for service on the Board, an additional annual cash retainer of $10,000 for service on the Audit Committee, an additional annual cash retainer of $7,500 for service on the Compensation Committee, and an additional annual cash retainer of $5,000 for service on the Nominating and Corporate Governance Committee, in each case, pro-rated for any partial year of service. On October 21, 2024, Ms. Krevans also received an initial equity-based award of 31,055 restricted stock units pursuant to the Non-Employee Director Compensation Program, which will vest in substantially equal installments over three years following the grant date, subject to Ms. Krevans' continued service through the applicable vesting date. In addition, subject to her service on the Board as of the date of each annual meeting of the Company's stockholders, Ms. Krevans will automatically be granted an equity-based award of restricted stock units having a grant date value equal to $250,000, which will vest in full on the earlier of the one year anniversary of the grant date or the date of the next annual meeting of the Company's stockholders, subject to Ms. Krevans' continued service through

01

Item 7.01 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 21, 2024, the Company issued a press release announcing Ms. Krevans' appointment to the Board described above. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits. 99.1 Press Release, dated October 21, 2024 104 Cover Page Interactive Data File

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GRAIL, INC. Date: October 22, 2024 By: /s/ Abram Barth Name: Abram Barth Title: General Counsel and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR